Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
Authors:
- Xianguo WuXWXianguo Wu
- Xingguo LuXLXingguo Lu
- Gang ChenGCGang Chen
- Xiongwei YeXYXiongwei Ye
- Jian HuangJHJian Huang
- 1 January 2009
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 123 (3) , 537-542
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Guideline on prevention and treatment of chronic hepatitis B in China (2005)Chinese Medical Journal, 2007
- How to modulate inflammatory cytokines in liver diseasesLiver International, 2006
- Treatment of chronic hepatitis BNature Clinical Practice Gastroenterology & Hepatology, 2006
- The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortalityClinical Microbiology and Infection, 2004
- Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarctionBlood, 2002
- Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)Cancer Gene Therapy, 2000
- Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 1999
- Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancersInternational Journal of Cancer, 1998
- Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase ReceptorJournal of Biological Chemistry, 1995
- Biochemical and biological aspects of the plasminogen activation systemClinical Biochemistry, 1990